ArticleBMC musculoskeletal disorders2026
Association of anterior necrotic boundary location with collapse progression in symptomatic osteonecrosis of the femoral head: analysis of ARCO 2021 type 2 lesions.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveAnterior necrotic boundary location and collapse progression in symptomatic osteonecrosis of the femoral head remain incompletely understood. We investigated whether anterior necrotic boundary location is associated with collapse progression in symptomatic osteonecrosis classified as ARCO 2021 type 2. MATERIALS AND
methodsThirty-seven hips in 33 patients with symptomatic post-collapse osteonecrosis (ARCO 2021 type 1 or 2) followed conservatively for more than 1 year were retrospectively reviewed. The anterior necrotic boundary angle (ANBA) was measured on mid-sagittal CT as the angle between a line drawn from the femoral head center to the anterior necrotic margin and a vertical reference line. Collapse width was measured on serial biplane radiographs, and progression was defined as a ≥ 1 mm increase. Receiver operating characteristic analysis determined the optimal ANBA cut-off, and Kaplan-Meier analysis evaluated progression-free survival.
resultsNo collapse progression occurred in two ARCO 2021 type 1 hips, whereas 25 of 35 type 2 hips (71%) demonstrated progression. ANBA was significantly greater in hips with progression (P = 0.0019). The optimal ANBA cut-off for predicting progression was 75° (area under the curve, 0.840). Hips with ANBA ≥ 75° showed significantly lower progression-free survival than those with ANBA < 75° (P = 0.0029).
conclusionAnterior necrotic boundary location is associated with collapse progression in symptomatic ARCO 2021 type 2 ONFH. ANBA may serve as a CT-based imaging parameter for risk stratification after initial collapse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.